Plain-English translation of NCT06375122 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This is a long-term research study for people diagnosed with Kaposi sarcoma, a type of cancer caused by a virus (KSHV) that most commonly affects the skin but can also affect lymph nodes, lungs, and the digestive tract. Researchers want to understand how this disease develops and changes in different people over time by collecting medical information, tissue samples, blood, and saliva as you receive your regular cancer care.
Kaposi sarcoma is not fully understood — it behaves differently in different people, and doctors need better information about how it progresses and responds to treatment. By studying the natural course of this disease over time, researchers hope to develop more effective treatments and better ways to predict which patients will improve, have remission, or experience recurrence.
You likely qualify if…
You likely don't qualify if…
You would continue receiving your regular Kaposi sarcoma care while researchers collect information about your disease. Over the course of the study, you would provide tissue samples from your Kaposi sarcoma lesions, blood and saliva samples, answer questions about your health and symptoms, and allow researchers to review your medical records and imaging scans. Researchers will follow you over a long period to track patterns in how your disease responds to treatment, whether it goes away or returns, and what factors influence these outcomes.
AI-generated summary from trial data · Jun 9, 2026 · Not medical advice
United States